Ascend Wellness Holdings (AAWH) EBITDA (2020 - 2026)

Ascend Wellness Holdings has reported EBITDA for 7 years, with the latest figure at $5.3 million in Q2 2026.

• On a quarterly basis, EBITDA rose 626.95% year-over-year to $5.3 million in Q2 2026; TTM through Jun 2026 was -$10.7 million, a 306.58% decrease from a year earlier, with the FY2025 full-year figure at -$17.0 million, down 459.36% from the prior year.
• EBITDA was $5.3 million for Q2 2026 at Ascend Wellness Holdings, up from $2.5 million in the prior quarter.
• The five-year high for EBITDA was $6.1 million in Q4 2024, with the low at -$17.2 million in Q4 2025.
• Average EBITDA over 5 years is -$866500.0, with a median of $409500.0 recorded in 2023.
• The sharpest annual moves came in 2023 and 2024: EBITDA slumped 1219.83% in 2023, then soared 981.21% in 2024.
• Over 5 years, EBITDA stood at $5.4 million in 2022, then sank by 89.52% to $564000.0 in 2023, then jumped by 981.21% to $6.1 million in 2024, then plunged by 381.58% to -$17.2 million in 2025, then surged by 130.75% to $5.3 million in 2026.
• The last three EBITDA figures came in at $5.3 million (Q2 2026), $2.5 million (Q1 2026), and -$17.2 million (Q4 2025), per Business Quant data.